Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe addition of fentanyl to 1.5mgml ropivacaine has no advantage for paediatric epidural analgesia
Acta Anaesthesiologica Scandinavica, 08/12/09
Cho JE et al. – The addition of 0.2 mcg/kg/h fentanyl to 1.5 mg/ml ropivacaine increased the incidence of side effects without improvement of analgesia in infants and children undergoing hypospadias repair. The use of plain 1.25 mg/ml ropivacaine increased the need for rescue analgesia and this could be compensated by addition of fentanyl.
Related Articles
Advances in labor analgesia
International Journal of Women's Health, 10/07/09
Relevance Score: 70%
Techniques of epidural block
Anaesthesia & intensive care medicine, 11/05/09
Relevance Score: 69%
Is Intravenous Patient Controlled Analgesia Enough for Pain Control in Patients Who Underwent Thoracoscopy?
Journal of Korean Medical Science, 10/01/09
Relevance Score: 69%
Epidural analgesia and labor
European Journal of Pain, 11/12/09
Relevance Score: 68%
Less Urinary Tract Infection by Earlier Removal of Bladder Catheter in Surgical Patients Receiving Thoracic Epidural Analgesia
Regional Anesthesia and Pain Medicine, 11/04/09
Relevance Score: 67%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
BMC Infectious Diseases, 12/03/09
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/03/09
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09
Sponsor
Article Search
Sponsor